Skinbiotherapeutics Share Discussion Threads

[rayrac] 03/9/2018 15:30

They haven’t even trialed the so-called, ingredient yet! Just a load of waffle from her and a load of greenhorn followers, not having a clue what they are throwing their cash at.

[owenmo] 03/9/2018 15:13

Asterix this could turn nasty and throw us way off topic :) You say tomayto and I say tomahto, you say spelt and I say spelled, the former found at the bread counter; finally I say "correctly" :) Criteria here are slipping.

[alanrussell] 03/9/2018 13:47

I do remember being given a note by a secretary as few years ago to return a phone call from a Mr. Duncan. The note however read Mr. Dunkin as in the doughnuts. Not easy laughing and crying at the same time.

[asterix96] 03/9/2018 13:39

It was spelt correct, these day you could expect "Crytearea"

[owenmo] 03/9/2018 11:54

Previous RNS here was found wanting in terms of poor communication it seems. Current one falls short (not a capital offence) as regards syntax. Is there no-one within the confines of a PR operation, where after all language and communication is of the essence, the life-blood, with the cop-on, the savvy, the awareness, to allow that “criteria̶1; is a plural noun. “The criteria has been met” indeed. ‘Struth.

[scottishfield] 03/9/2018 10:10

Added also.

[onedayrodders] 03/9/2018 10:09

Buying a tad disappointing.

However took the opportunity to double my position while the market dozes.

[cabster] 03/9/2018 09:07

Falling as it is to agree with costax he’s right. If it breaks 22 could see 30 in short order.

[costax1654x] 03/9/2018 09:00

Trial RNS will take us over 30 easily.Results of trials over 40-50

[costax1654x] 03/9/2018 09:00

A bit of patience here will be highly rewarded

[manc10] 03/9/2018 08:19

Depressed troll alert apfindley

[slartybartfaster] 03/9/2018 08:11

apfindley, ok for you to ramp one media.

[costax1654x] 03/9/2018 08:08

I think just an idiot will sell in the next 2 weeks...Before trials...Potential 100%+ rerate

[costax1654x] 03/9/2018 08:05

Ramped?you are silly!!!Have you seen the RNS?

[apfindley] 03/9/2018 08:03

Beware. This is being ramped on many boards by Costax

[slartybartfaster] 03/9/2018 07:31

elrico called it.

[rafboy] 03/9/2018 07:17

This is very good news. Expect decent buying today.

[primal123] 03/9/2018 07:05

SkinBiotix(R) technology successful in stability testingManchester, UK - 3 September 2018 - SkinBioTherapeutics plc (AIM: SBTX, the "Company"), a life science company focused on skin health, is pleased to provide an update to its announcement of 16 August 2018. The stability criteria required for its human study has been met and the Company expects to commence the study in September as planned.

[slartybartfaster] 02/9/2018 05:20

Cath

There are two separate matters here:
The Skinbiotix that we eventually want to commercialise is the freeze dried version. The freeze drying gives it stability and a long shelf life. The fact that we can now freeze dry it is an important milestone.

The cream is required so that we can do our study in humans. Remember that the cream ISN’T a product – we’re not trying to commercialise the cream. The reason for making the cream is so we have something to rub into people on the trial. Achieving longer term stability in a formulation (the cream) is a normal challenge of the development process and consequently one that we’re familiar with tackling.

I also asked Cath what the minimum stability period was required for the human trials?

"Whilst we need long term stability overall, for the study it can be less since at the half way point each participant gets a new bottle which is also common practice during studies of this kind."

SOH

The SBTX RNS is a very positive RNS. Manufacturing scale up was the biggest risk and this has been achieved with a partner!!. Also the ability to freeze dry is a major step forward as that gives you extended shelf life for the SkinBiotix technology which is key for partners looking to incorporate this sort of ingredient into products. Product stability is typically a matter of formulation once your lysate is stable. The RNS doesn’t say the cream is not stable for longer than 24 hours. Its says they have tested it for 24 hours and they are now testing for longer in preparation for the studies. This is all part of the development process and they are updating investors as to this process

[owenmo] 01/9/2018 13:33

Correction: incorporating "LP-LDL" of course.

[owenmo] 01/9/2018 13:30

Swiss corporation Olliscience have just launched Ollibiotic incorporating LD-LDL. Presumably an announcement will emanate from Opti sooner rather than later. Reason for mentioning it on this board is that (a) I, like many, have departed the sister Opti BB in favour of an alternative and (b) among Olliscience platforms we find "Santé et anti-age". Opti/Olli alliance, of necessity, will bring SBTX into this mix, all things being equal. Jigsaw piecing together gradually, patiently, professionally, plausibly and with integrity - as only one would expect in an ethical, science-driven, profit-focused enterprise.